knowledge -WSS

knowledge

author：explore 2025-09-29 18:18:29 - browse：886

Boston Globe

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as allergy season is about to start.

In a move unusual for such a widely used drug, GlaxoSmithKline discontinued Flovent HFA, the brand name of its corticosteroid treatment fluticasone propionate, at the end of December. Critics, including Massachusetts Senator Elizabeth Warren, say the decision helps the company avoid new Medicaid penalties going into effect this year for medications with price increases that outpace inflation.

“It was all very confusing, and we were left scrambling, trying to find out what we could do,” said Simone Fung, whose 5-year-old son, David, endured worse asthma symptoms over the past two months as the Cambridge family navigated confusing insurance policies and shortages of alternative medications to find a replacement for Flovent.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Leukemia patients are helped by Syndax's new type of therapy

hotspot

focus

WSS

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Spinal cord stimulation reduces pain in amputees, study finds

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Adidas to release second batch of Yeezy sneakers after breakup with Ye

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

Wikipedia

knowledge

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Poland's lawmakers approve a divisive law on Russian influence

George Santos makes 1st court appearance after pleading not guilty to 13 counts

5 wounded, 2 critically, in Michigan shopping center shooting

What does generative AI mean for health care? We asked experts

What AstraZeneca

Supreme Court strikes down use of affirmative action

Pfizer plans to depart BIO

Dobbs anniversary: the lost opportunity of abortion as health care

Doctors increasingly discourage vaping amid mounting health concerns

focus

FDA approves world's first CRISPR

Americans' trust in science, scientist continues decline: Report

Judge orders hearing on Trump's motion to disqualify Fulton County DA

FDA needs staff influx to meet gene therapy needs, Marks says

Teacher posts viral 'school supply rant' with advice for parents

Doctors increasingly discourage vaping amid mounting health concerns

focus

hotspot

focus

leisure time